SNY - Sanofi

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
Currency in EUR. All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue43,474,00036,608,00037,870,000
Cost of Revenue13,943,00011,288,00011,861,000
Gross Profit29,532,00025,320,00026,008,000
Operating Expenses
Research Development6,571,0005,455,0005,521,000
Selling General and Administrative12,264,00010,281,00010,361,000
Non Recurring1,488,000907,0001,697,000
Others2,241,0001,785,0002,321,000
Total Operating Expenses22,564,00018,428,00019,900,000
Operating Income or Loss6,968,0006,892,0006,109,000
Income from Continuing Operations
Total Other Income/Expenses Net5,752,000403,00058,000
Earnings Before Interest and Taxes12,720,0007,295,0006,168,000
Interest Expense504,000975,000607,000
Income Before Tax12,216,0006,320,0005,561,000
Income Tax Expense2,068,0001,399,000770,000
Minority Interest203,000179,000175,000
Net Income From Continuing Ops10,128,0004,967,0004,657,000
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income10,128,0004,967,0004,657,000
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares10,128,0004,967,0004,657,000